Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 17/20 | 1.00 |
| ▸ | MPEG1 | Q2M385 | 11/20 | 1.00 |
| ▸ | XIAP | P98170 | 5/20 | 1.00 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | PTGES | O14684 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | KAT2B | Q92831 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12757276 | 1.00 | ALOX5 (1.00) | ALOX5MPEG1XIAPGPR84KDM4E | |
| Rapanone SCHEMBL2311835 | 1.00 | ALOX5 (1.00) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL6410428 | 0.98 | ALOX5 (0.97) | ALOX5MPEG1XIAPGPR84KDM4E | |
| Embelin SCHEMBL4653231 | 0.94 | ALOX5 (0.88) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL9580649 | 0.91 | ALOX5 (0.83) | ALOX5MPEG1XIAPGPR84KDM4E | |
| Embelin SCHEMBL21905447 | 0.90 | ALOX5 (0.81) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL12830675 | 0.85 | ALOX5 (0.74) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL17123718 | 0.85 | ALOX5 (0.73) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL19236537 | 0.83 | ALOX5 (0.71) | ALOX5MPEG1XIAPGPR84KDM4E | |
| SCHEMBL11148794 | 0.81 | ALOX5 (0.68) | ALOX5MPEG1XIAPGPR84KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250092269-A1 | ANTI-BIOFOULING COMPOSITION | Montana Technological University | 2025-03-20 | — | — | US | claimed |
| WO-2025049793-A1 | SOLID COMPOSITIONS FOR PRODUCTION OF MICELLES FOR DRUG DELIVERY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-03-06 | — | — | WO | claimed |
| EP-4507781-A1 | DEVICE FOR TREATING A TISSUE PORTION OF A HUMAN OR ANIMAL | Klose, Thomas (DE) | 2025-02-19 | — | — | EP | claimed |
| WO-2025032553-A1 | METHODS OF TREATING INNER EAR FIBROSIS | COCHLEAR LIMITED (AU) | 2025-02-13 | — | — | WO | claimed |
| US-12150969-B2 | Synthetically enveloped virus | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-11-26 | — | — | US | claimed |
| CN-118993869-A | Marine fungus-derived benzoquinone derivative embelin A and preparation method and application thereof | 中国科学院南海海洋研究所 | 2024-11-22 | — | — | CN | claimed |
| CN-118795124-A | Biomarker for predicting aging and application thereof | 深圳华大生命科学研究院 | 2024-10-18 | — | — | CN | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20240307337-A1 | Method Of Treatment Of Obesity | QUEEN MARY UNIVERSITY OF LONDON (GB) | 2024-09-19 | — | — | US | claimed |
| WO-2024175554-A1 | TRAIL AGONISTS FOR USE IN THE TREATMENT OF CANCER IN PATIENTS HAVING AN ACTIVATING ALTERATION OF FGFR3 | INSTITUT CURIE (FR) | 2024-08-29 | — | — | WO | claimed |
| US-20060069042-A1 | Cytochrome P450 2C9 inhibitors | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2006-03-30 | — | — | US | claimed |
| WO-2005092326-A1 | SMALL MOLECULE ANTAGONISTS OF XIAP FAMILY PROTEINS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2005-10-06 | — | — | WO | claimed |
| US-20040152760-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2004-08-05 | — | — | US | claimed |
| JP-2003532634-A | — | — | 2003-11-05 | — | — | JP | claimed |
| EP-1244435-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES | Proteotech Inc. (US) | 2002-10-02 | — | — | EP | claimed |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTAMED, INC. | 2001-11-29 | — | — | US | claimed |
| WO-2001049281-A2 | POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND α-SYNUCLEIN FIBRIL DISEASES | PROTEOTECH, INC. (US) | 2001-07-12 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12150969-B2 | Synthetically enveloped virus | PIGS, LIPG, FURIN | ALOX5 1873/4885MPEG1 829/4885XIAP 1888/4885 |
| US-20010047032-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | ALOX5 1538/4885MPEG1 2104/4885XIAP 352/4885 |
| US-20040152760-A1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | SNCA, PARK7, HTT | ALOX5 1538/4885MPEG1 2104/4885XIAP 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.